JP2002524092A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524092A5
JP2002524092A5 JP2000569230A JP2000569230A JP2002524092A5 JP 2002524092 A5 JP2002524092 A5 JP 2002524092A5 JP 2000569230 A JP2000569230 A JP 2000569230A JP 2000569230 A JP2000569230 A JP 2000569230A JP 2002524092 A5 JP2002524092 A5 JP 2002524092A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000569230A
Other versions
JP3732408B2 (ja
JP2002524092A (ja
Filing date
Publication date
Priority claimed from US09/148,712 external-priority patent/US6441140B1/en
Application filed filed Critical
Publication of JP2002524092A publication Critical patent/JP2002524092A/ja
Publication of JP2002524092A5 publication Critical patent/JP2002524092A5/ja
Application granted granted Critical
Publication of JP3732408B2 publication Critical patent/JP3732408B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000569230A 1998-09-04 1999-08-26 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生 Expired - Lifetime JP3732408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/148,712 US6441140B1 (en) 1998-09-04 1998-09-04 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US09/148,712 1998-09-04
PCT/US1999/019597 WO2000014536A1 (en) 1998-09-04 1999-08-26 Production of motif-specific and context-independent antibodies using peptide libraries as antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005260207A Division JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Publications (3)

Publication Number Publication Date
JP2002524092A JP2002524092A (ja) 2002-08-06
JP2002524092A5 true JP2002524092A5 (ja) 2005-12-22
JP3732408B2 JP3732408B2 (ja) 2006-01-05

Family

ID=22527002

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000569230A Expired - Lifetime JP3732408B2 (ja) 1998-09-04 1999-08-26 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2005260207A Expired - Lifetime JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2012058996A Expired - Lifetime JP5648007B2 (ja) 1998-09-04 2012-03-15 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2014036821A Withdrawn JP2014132019A (ja) 1998-09-04 2014-02-27 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2016113229A Pending JP2016210783A (ja) 1998-09-04 2016-06-07 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2005260207A Expired - Lifetime JP5013693B2 (ja) 1998-09-04 2005-09-08 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2012058996A Expired - Lifetime JP5648007B2 (ja) 1998-09-04 2012-03-15 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2014036821A Withdrawn JP2014132019A (ja) 1998-09-04 2014-02-27 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生
JP2016113229A Pending JP2016210783A (ja) 1998-09-04 2016-06-07 抗原としてペプチドライブラリーを用いたモチーフ特異性および状況独立性抗体の産生

Country Status (6)

Country Link
US (5) US6441140B1 (ja)
EP (3) EP1110086B1 (ja)
JP (5) JP3732408B2 (ja)
CA (1) CA2341143C (ja)
DE (1) DE69936389T2 (ja)
WO (1) WO2000014536A1 (ja)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884597B1 (en) * 1998-01-20 2005-04-26 Medical & Biological Laboratories, Co., Ltd. Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes
US6441140B1 (en) * 1998-09-04 2002-08-27 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US7198896B2 (en) * 1998-09-04 2007-04-03 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US9085609B2 (en) * 1998-09-04 2015-07-21 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US20120244594A9 (en) * 1998-09-04 2012-09-27 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US7300753B2 (en) * 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US7208581B1 (en) * 1999-11-05 2007-04-24 The Burnham Institute TRAF family proteins
WO2001049709A1 (en) * 2000-01-03 2001-07-12 Ramot University Authority For Applied Research & Industrial Development Ltd. Glycogen synthase kinase-3 inhibitors
WO2001083518A2 (en) * 2000-05-04 2001-11-08 Mount Sinai Hospital Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
US20020102248A1 (en) * 2000-09-06 2002-08-01 The Government Of The United States Of America Modulating response to genotoxic stress
US7425430B2 (en) * 2001-03-23 2008-09-16 Japan Science And Technology Corporation Probe for visualizing phosphorylation/dephosphorylation of protein and method of detecting and quantifying phosphorylation/dephosphorylation of protein
DE02747916T1 (de) 2001-06-21 2004-10-21 Cell Signaling Technology, Inc., Beverly Immunaffinitätsisolierung modifizierter peptide aus komplexen gemischen
US20110111424A1 (en) * 2001-06-21 2011-05-12 Cell Signaling Technology, Inc. Analysis of ubiquitinated polypeptides
US7378432B2 (en) * 2001-09-14 2008-05-27 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
US7166441B2 (en) * 2002-03-12 2007-01-23 Perseptive Biosystems Inc. Method and apparatus for the identification and quantification of biomolecules
GB0208104D0 (en) * 2002-04-09 2002-05-22 Univ Dundee Method
JP2006514104A (ja) 2002-12-12 2006-04-27 テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． グリコーゲンシンターゼキナーゼ−３阻害剤
EP1638557A4 (en) * 2003-06-27 2007-11-07 Univ Tel Aviv Future Tech Dev INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3
WO2005019831A2 (en) * 2003-08-18 2005-03-03 Tethys Bioscience, Inc. Methods for reducing complexity of a sample using small epitope antibodies
EP1668369B1 (en) * 2003-08-20 2016-01-06 ProMIS Neurosciences Inc. Epitope protection assay and method for detecting protein conformations
US20050064507A1 (en) * 2003-09-11 2005-03-24 James Stephen Shaw Determining kinase specificity
US7282339B2 (en) * 2003-09-17 2007-10-16 Invitrogen Corporation Competitive immunoassay
US8852879B2 (en) 2004-04-29 2014-10-07 The Children's Hospital Of Philadelphia Materials and methods for the detection of nitrated fibrinogen
US20050244905A1 (en) * 2004-04-29 2005-11-03 Harry Ischiropoulos Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
US7973134B2 (en) * 2004-07-07 2011-07-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
US20070048797A1 (en) * 2004-08-11 2007-03-01 Xing Su Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules
US7935790B2 (en) * 2004-10-04 2011-05-03 Cell Singaling Technology, Inc. Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
US20070224662A1 (en) * 2004-12-17 2007-09-27 Jun Luo Post-translational modification of proteins in cell-free expression systems
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2006106957A1 (ja) * 2005-04-01 2006-10-12 National University Corporation Hokkaido University ｐ５３翻訳後修飾部位を特異的に認識するモノクローナル抗体、及びその抗体を含む修飾部位測定キット
US20090099340A1 (en) * 2007-10-12 2009-04-16 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
WO2006117007A1 (en) * 2005-05-03 2006-11-09 The Antibody Project Aps Methods for obtaining antigen specific antibodies
US20060292642A1 (en) * 2005-06-24 2006-12-28 Javad Khosravi Immunoassay of phosphorylated proteins
US7906297B2 (en) 2005-07-20 2011-03-15 Cell Signaling Technology, Inc. Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof
EP1934867A2 (en) * 2005-08-31 2008-06-25 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
US20100151495A9 (en) * 2005-08-31 2010-06-17 Cell Signaling Technolgy, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
WO2007079755A1 (en) * 2006-01-12 2007-07-19 Janus Beierholm Holding Aps Reimmunization and antibody design
WO2008076139A1 (en) * 2006-03-10 2008-06-26 Tethys Bioscience, Inc. Multiplex protein fractionation
WO2007127335A2 (en) * 2006-04-27 2007-11-08 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
DK2027158T3 (da) * 2006-05-02 2013-01-14 Carviar Aps Metode til immunisering af en fugleart
US20090325312A1 (en) * 2006-05-12 2009-12-31 Ailan Guo Reagens for the detection of protein acetylation signaling pathways
US20150232540A1 (en) * 2006-07-11 2015-08-20 Cell Signaling Technology, Inc. Analysis of ubiquitnated polypeptides
US7939636B2 (en) * 2006-08-11 2011-05-10 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US20100092992A1 (en) * 2006-08-17 2010-04-15 Peter Hornbeck Lysine acetylation sites
US20090258442A1 (en) * 2006-08-31 2009-10-15 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
US20090068684A1 (en) * 2007-03-26 2009-03-12 Cell Signaling Technology, Inc. Serine and threoninephosphorylation sites
US20080238709A1 (en) * 2007-03-28 2008-10-02 Faramarz Vaziri One-way communication apparatus with dynamic key generation
US7977462B2 (en) 2007-04-19 2011-07-12 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
JP5564431B2 (ja) 2007-10-29 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼアラレノンアナログ化合物ががんを処置する能力を予測する方法
US20090220991A1 (en) * 2008-02-29 2009-09-03 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
EP2304439A4 (en) * 2008-05-29 2012-07-04 Nuclea Biotechnologies Llc ANTI-phospho-AKT ANTIBODY
US9868781B2 (en) * 2008-06-02 2018-01-16 Cornell University Antibodies for ubiquitinated proteins
US7933146B2 (en) * 2008-10-08 2011-04-26 Seagate Technology Llc Electronic devices utilizing spin torque transfer to flip magnetic orientation
WO2010051215A1 (en) * 2008-10-31 2010-05-06 Proteonova, Inc. Methods for making hiv vaccines and related compositions
WO2011056561A1 (en) * 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
US9453845B2 (en) 2010-02-01 2016-09-27 Cell Signaling Technology, Inc. Mass spectroscopy analysis of mutant polypeptides in biological samples
CA2794851A1 (en) * 2010-04-02 2011-10-06 Kalobios Pharmaceuticals, Inc. Generation of antibodies to an epitope of interest
FI20105715A0 (fi) * 2010-06-18 2010-06-18 Helsingin Yliopisto Asetyloituun HMGB1:een sitoutuva polyklonaalinen vasta-aine
US9249231B2 (en) 2010-11-05 2016-02-02 Cell Signaling Technology, Inc. Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motif
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
EP2755687A4 (en) * 2011-09-17 2015-04-08 Suzhou Naao New Material Sciences Co Ltd ANTIBODY RECOGNIZING AN EPITOPE ARBITRAIRED WITH AT LEAST THREE AMINO ACID RESIDUES IN A PEPTIDE, AND GENERATING METHOD THEREOF
EP2573565A1 (en) 2011-09-23 2013-03-27 Gerhard Matthias Kresbach Immune detection method for common epitopes of two or more analytes in samples of complex compositions, device, and kit for enabling said immune detection method
WO2013125221A1 (ja) * 2012-02-21 2013-08-29 静岡県 抗体精製用アフィニティリガンド
JP6293409B2 (ja) * 2012-10-04 2018-03-14 国立大学法人富山大学 抗原特異的ウサギ抗体産生細胞の迅速な特定方法およびその利用
CN105283196B (zh) 2013-03-15 2018-10-12 贝丝以色列女执事医疗中心 用于产生和使用构象-特异性抗体的方法和组合物
US10857243B2 (en) * 2014-04-09 2020-12-08 Brandeis University Enzymatically responsive magnetic particles and their use
WO2015155738A2 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
WO2015166036A1 (en) 2014-05-02 2015-11-05 Morphosys Ag Peptide libraries
EP3373950B1 (en) 2015-11-11 2024-05-01 Serimmune Inc. Methods and compositions for assessing antibody specificities
AU2018310860A1 (en) * 2017-08-04 2020-03-05 Abcam Plc Methods and compositions for the development of antibodies specific to epitope post-translational modification status
GB202012722D0 (en) * 2020-08-14 2020-09-30 Abcam Plc Validation method
CN116444677A (zh) * 2023-06-09 2023-07-18 中国人民解放军军事科学院军事医学研究院 一种FoxM1蛋白Y575磷酸化的多克隆抗体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227596A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd 抗リン酸化チロシンモノクロ−ナル抗体およびそれを産生するハイブリド−マ
EP0544942A1 (en) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel tools for the diagnosis and treatment of Alzheimer disease
JPH05244987A (ja) 1992-02-28 1993-09-24 Unitika Ltd 抗硫酸化チロシン抗体，その製造方法及び抗硫酸化チロシンモノクローナル抗体を産生するハイブリドーマ
US5532167A (en) * 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
US6001580A (en) * 1995-03-28 1999-12-14 Takeda Chemical Industries, Inc. Method for assaying ERK2 map kinase
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
FR2757864B1 (fr) 1996-12-30 1999-03-19 Centre Nat Rech Scient Anticorps reconnaissant specifiquement une proteine nitrosylee, leur procede de preparation, leur utilisation therapeutique et diagnostique
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
US6441140B1 (en) 1998-09-04 2002-08-27 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US9919577B2 (en) 2014-11-14 2018-03-20 Hyundai Motor Company Air-conditioning device for vehicle

Similar Documents

Publication Publication Date Title
BE2018C020I2 (ja)
BE2016C007I2 (ja)
BE2015C057I2 (ja)
BE2015C018I2 (ja)
BE2014C017I2 (ja)
BE2013C001I2 (ja)
BE2010C011I2 (ja)
BE2008C046I2 (ja)
BE1025464I2 (ja)
JP2002525728A5 (ja)
HU0004964D0 (ja)
BRPI0017527B8 (ja)
JP2002532990A5 (ja)
BE2008C047I2 (ja)
BRPI0001672A2 (ja)
JP2002544565A5 (ja)
JP2002517451A5 (ja)
BRPI0001542A2 (ja)
JP2002506759A5 (ja)
JP2002511554A5 (ja)
BRPI0012675B8 (ja)
BRPI0017522A2 (ja)
BRMU7902607U2 (ja)
IN192931B (ja)
CN3097510S (ja)